A Prospective Observational Study Comparing Computer-Assisted Paramedian Approach Versus Conventional Midline Approach for Lumbar Puncture
1 other identifier
interventional
84
0 countries
N/A
Brief Summary
The goal of this clinical trial is to compare the effects of CMPAT and MAT in patients undergoing LP. Participants will be randomly assigned to either the CMPAT treatment group (group A) or the MAT treatment group (group B). Researchers will compare CMPAT treatment group and the MAT treatment group to see if the number of needle insertion attempts required for a successful LP, the puncture success rate, pain assessment in the back, head, and legs, and the occurrence of complications have different.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2024
CompletedFirst Posted
Study publicly available on registry
May 17, 2024
CompletedStudy Start
First participant enrolled
October 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2025
CompletedMay 17, 2024
February 1, 2024
1 year
May 14, 2024
May 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of needle insertion attempts for successful LP
A successful puncture was defined as the presence of CSF outflow from the puncture needle. The number of needle insertion attempts was determined by the number of times the puncture needle was inserted into the target area.
30 minutes following treatment
Secondary Outcomes (3)
LP success rate
30 minutes following treatment
Assessment of back, head and leg pain using the NRS
before treatment, during surgery and 30 minutes,6 hours,1 days,3 days,7 days,2 weeks,4 weeks following treatment
Adverse events and other unintended effects
during surgery and 30 minutes,6 hours,1 days,3 days,7 days,2 weeks,4 weeks following treatment
Other Outcomes (4)
Locating time
30 minutes following treatment
Puncture time
30 minutes following treatment
Evaluation from physician
30 minutes following treatment
- +1 more other outcomes
Study Arms (2)
Computer-Assisted Paramedian Approac Technique
EXPERIMENTALThe L3-4 inter-laminar space will be selected as the target for puncture, and in the longitudinal direction, 1.0-1.5cm will be opened beside the upper edge of the spinous process (tip) of the lower vertebra as the entry point. The lumbar puncture needle will be inserted vertically along the axis of the anesthesia needle. The puncture path will be maintained completely perpendicular to the skin until the needle reached the PLTLF (posterior layer of the thoracolumbar fascia), where some resistance will be felt. The puncture direction is adjusted as needed. The tip of the needle will be tilted 20±10° in the sagittal direction and 15±5° inward such that the tip will point at the midpoint of the spinal canal. After the needle reaches the PLTLF, it will be further inserted 3-7 cm.
Conventional Midline Approach Technique
EXPERIMENTALPuncture will be performed on the posterior median line near the midpoint of the L3-4 Space of spinous process. The lumbar puncture needle will be inserted vertically along the axis of the anesthesia needle, or the tip of the needle will be tilted 15° in the sagittal direction toward the head, so that the needle path is parallel to the space of spinous process.
Interventions
Computer-Assisted Paramedian Approach Technique
Conventional Midline Approach Technique
Eligibility Criteria
You may qualify if:
- Aged 18-99 years. Indication for lumber puncture (diagnostic lumbar puncture, analysis of cerebrospinal fluid composition, measurement of cerebrospinal fluid pressure, release of cerebrospinal fluid, lumbar cistern drain-age or intrathecal injection).
- Body mass index between 18.5 and 35 kg/m2.
You may not qualify if:
- Cerebral hernia or known high cerebrospinal fluid pressure prone to cerebral hernia.
- Oral anticoagulant or antiplatelet therapy (≤3 days) or coagulation dysfunction, various factors lead to a higher risk of bleeding.
- Active infection or prior infection at the surgical site.
- Skin breakdown.
- Previous spine fusion surgery.
- Cauda equina syndrome.
- Pregnancy or breast feeding.
- Severe comorbid medical or psychiatric disorder.
- Unwilling to adhere to any of the required procedures.
- Cognitive impairment interfering with participant's ability to give full and - - informed consent or complete the baseline or follow-up assessments.
- Survival expectation less than 1 month.
- Moving abroad in 1 month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2024
First Posted
May 17, 2024
Study Start
October 28, 2024
Primary Completion
October 28, 2025
Study Completion
October 28, 2025
Last Updated
May 17, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share